NUTR
Nusatrip Incorporated
9.00$
+0.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 16 | Q1 17 | Q2 17 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.2% | +8.4% | – | – | – | – | – | +121.9% | +21.3% | +39.7% | +40.3% | |
| – | +1.3% | +4.2% | – | – | – | – | – | +135.2% | +22.4% | +40.3% | +41.2% | |
| – | -2.9% | -31.9% | – | – | – | – | – | +105.7% | -13.2% | +15.0% | -26.3% | |
| – | -2.9% | -31.9% | – | – | – | – | – | +105.7% | -13.2% | +15.0% | -26.3% | |
| – | +14.9% | +1.7% | – | – | – | – | – | +268.8% | +84.6% | -49.8% | +227.1% | |
| – | -0.9% | +5.0% | – | – | – | – | – | -60.4% | +8.8% | -35.6% | -66.0% | |
| – | +0.0% | +24.8% | – | – | – | – | – | – | – | – | – | |
| – | -4.0% | +37.9% | – | – | – | – | – | -18.8% | -18.5% | -16.0% | -25.5% | |
| – | -5.4% | +31.1% | – | – | – | – | – | +56.3% | +6.5% | +25.4% | -28.6% | |
| – | -1.3% | +14.1% | – | – | – | – | – | +57.1% | +6.6% | +25.5% | -28.9% | |
| – | -7.6% | +38.4% | – | – | – | – | – | -21.4% | -26.6% | +95.9% | -64.0% | |
| – | -2.9% | +7.7% | – | – | – | – | – | -39.1% | +231.4% | +191.6% | -75.1% | |
| – | +2.1% | +1.3% | – | – | – | – | – | – | – | – | – | |
| – | +1.9% | +1.0% | – | – | – | – | – | – | – | – | – | |
| – | +0.2% | +0.1% | +85.1% | +0.0% | +10.0% | +0.0% | -9.1% | +0.0% | +10.0% | -80.7% | +52.5% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.